| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,835.50
|
|
Change (%)
|
-30.50 (-1.63%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,835.50
-
1,875.00
|
|
52-Week Range (RS)
|
1,547.25
-
2,047.55
|
|
Beta (1 Year)
|
0.45
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharmaceutical Industries Ltd drops for fifth straight session |
| Sun Pharma incorporates subsidiary in IFSC, Gift City |
| Sun Pharma update on Lipitor antitrust litigation in US court |
| Sun Pharma receives favorable court ruling in Lipitor patent settlement case in US |
| Sun Pharmaceutical Industries receives ratings action from CRISIL |
| Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter |
| Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives growth |
| Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions |
| Sun Pharma receives Organon shareholders approval for merger |
| Sun Pharma receives approval to market semaglutide injection in South Africa |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
11-Sep-2026 |
1842.00 |
-0.35 |
| 1Month |
18-Aug-2026 |
1876.40 |
-2.18 |
| 3Month |
18-Jun-2026 |
1824.00 |
0.63 |
| 6Month |
18-Mar-2026 |
1778.75 |
3.19 |
| 1Year |
18-Sep-2025 |
1648.90 |
11.32 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.91 |
4076.55 |
| SBI BSE SENSEX ETF |
2.32 |
2823.56 |
| ICICI Pru Value Fund |
4.55 |
2733.05 |
| ICICI Pru Aggressive Hybrid Fund |
3.73 |
1955.63 |
| ICICI Pru Large Cap Fund |
2.24 |
1799.97 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Zydus Lifesciences Ltd |
1,153.00 |
1.38 |
1,205.65 |
835.85 |
115,012.19 |
| Cipla Ltd |
1,371.45 |
-0.06 |
1,672.20 |
1,165.55 |
110,793.75 |
| Laurus Labs Ltd |
1,955.25 |
-0.06 |
1,981.45 |
822.85 |
105,644.55 |
| Aurobindo Pharma Ltd |
1,735.00 |
3.03 |
1,735.00 |
1,066.00 |
99,828.07 |
| Lupin Ltd |
2,144.70 |
2.52 |
2,530.00 |
1,900.30 |
98,069.81 |
|
|
|
|